May 20, 2005 -- The decisive factor for launching the newest fund has been the actuality that investors realized, that especially in bear markets - when stocks are falling - they are
better off with a market neutral products. The main advantage of the Salus Alpha Equity Market Neutral (SAEMN) is the fact that is designed to show a good performance in rising as well as
in falling markets.
Oliver Prock, Managing Director, about the latest fund in the product-family: "The Salus Alpha Team offers its customers innovative products with daily liquidity and market neutral
performance. With our 5th fund the Salus Alpha Equity Market Neutral, we once again managed to be one step ahead of the market and to anticipate the trend for market neutral products.
Fund Information
The Salus Alpha Equity Market Neutral (Dividend Paying AT0000495080, Non-Dividend Paying (T) AT0000495098, Non-Dividend Paying (VT)AT0000495106) is a market neutral long-short equity
fund. The Fund seeks to produce capital appreciation while having a low correlation to the U.S. equity market. In addition, it seeks to produce lower volatility than would result from a
long-only investment in the U.S. equity market. The Salus Alpha Equity Market Neutral has a minimum investment of EUR 5,000; savings plans start with EUR 100.
About Salus Alpha
Salus Alpha founded in 2001, is a leading provider of alternative investment solutions. Salus Alpha is headquartered in Switzerland, and has offices in Vienna and New York. Salus Alpha
has launched 4 funds namely: the Salus Alpha Global Fund, the Absolute Return S.A., the Absolute Return S.A. Institutional and the Salus Alpha Managed Futures. The Salus Alpha investment
process is based upon three equally important criteria: strategy allocation (Top Down), manager allocation (Bottom Up) and continuous monitoring (Risk Management).
For further information, please contact: e-mail protected from spam bots